Kiora Pharmaceuticals, Inc.
(Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of orphan retinal diseases. Publicly traded on the NASDAQ under KPRX, our mission is to help patients restore vision.
Revitalized with a new energy
Kiora’s pipeline is comprised of multiple New Chemical Entities for the restoration of vision in patients with orphan retinal diseases. Stay tuned as we advance these assets with key clinical milestones in the upcoming 12 to 18 months.
